Table 1.
The details of 12 COVID-19 patients with cancer in Zhongnan Hospital of Wuhan University
Age (years) |
Gender | Clinical Type | Cancer Type | Anticancer treatments in the past month | Comorbidities | ICU Admission | Invasive ventilation | Death | |
---|---|---|---|---|---|---|---|---|---|
Case 1 | 44 | Female | Mild | Thyroid cancer | None | None | No | No | No |
Case 2 | 64 | Male | Mild | Lung cancer | None | Hypertension | No | No | No |
Case 3 | 37 | Male | Critical | Liver cancer | Surgery (Right hepatectomy) | None | Yes | No | No |
Case 4 | 60 | Male | Mild | B cell non-hodgkin's lymphoma | None | Diabetes, Mellitus; Tuberculosis | No | No | No |
Case 5 | 46 | Female | Severe | Thyroid cancer | None | None | No | No | No |
Case 6 | 67 | Female | Critical | Esophageal cancer | Surgery (Radical resection of esophageal cancer) |
CHD; | Yes | Yes | Yes |
Case 7 | 48 | Female | Mild | Breast cancer | Adjuvant chemotherapy (docetaxel + pirarubicin) | None | No | No | No |
Case 8 | 57 | Male | Mild | Colon cancer | Palliative chemotherapy (capecitabine) | None | No | No | No |
Case 9 | 57 | Male | Mild | Lung cancer | Radiotherapy (mediastinum) | None | No | No | No |
Case 10 | 61 | Male | Critical | Lung cancer | Chemotherapy+ Immunotherapy (docetaxel+ cisplatinum+ camrelizumab) | None | Yes | Yes | Yes |
Case 11 | 78 | Female | Critical | Chronic lymphocytic leukemia | None | Hypertension, CHD, COPD |
Yes | No* | Yes |
Case 12 | 43 | Female | Mild | Nasopharyngeal cancer | Neoadjuvant chemotherapy (docetaxel+ cisplatinum+ fluorouracil) |
None | No | No | No |
*The patient refused invasive ventilation.
Abbreviations: ICU, Intensive care unit; CHD, Coronary heart disease; COPD, Chronic obstructive pulmonary disease.